BPR0L075 is a heterocyclic 3-aroylindole microtubule-destabilizing agent, which interferes with tumor cell microtubule dynamics, leads to cancer cell cycle arrest and cell death by caspase-3 mediated apoptosis [20] and antiangiogenic effects [21]. Here, CASP3 is linked to cancer.